SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-014621
Filing Date
2022-05-20
Accepted
2022-05-20 16:30:25
Documents
13
Period of Report
2022-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53608
2 ex10-1.htm EX-10.1 121323
  Complete submission text file 0001493152-22-014621.txt   379036

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE prvb-20220517.xsd EX-101.SCH 2974
4 XBRL LABEL FILE prvb-20220517_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE prvb-20220517_pre.xml EX-101.PRE 22799
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3764
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38552 | Film No.: 22948034
SIC: 2834 Pharmaceutical Preparations